National Cord Blood Program
New York Blood CenterPublic HLA SearchTransplant Center Log-in
About usNCBP at WorkPatients and OutcomesCord Blood DonationsNews And ArticlesHow To HelpCord Blood Q and A

 



Disclaimer:

The information on this Website is general in scope and is not intended for promotional or advertising purposes. It is intended as a means of communication between the New York Blood Center's National Cord Blood Program, the communities it serves and the general public. The information provided throughout this Website is intended for educational purposes. It is not intended to provide or take the place of personal medical advice, diagnosis or treatment. NCBP strongly suggests that this resource should not be your only source of information and education on these topics. Always seek the advice of your physician or other qualified health care provider with any question you may have about a medical condition or treatment.

As stated in detail on the NCBP Homepage, the New York Blood Center's National Cord Blood Program operates under an Investigational New Drug (IND) exemption issued by the U.S. Food & Drug Administration (FDA). As such, "transplant patients" accepted into clinical protocols are considered "human research subjects" and are entitled to protections under pertinent FDA and U.S. Office for Human Research Protections (OHRP) rules.

The names, trademarks, service marks and logos of the New York Blood Center and the National Cord Blood Program appearing on this Website may not be used in any advertising, publicity, or to indicate NYBC/NCBP affiliations with any product or service without NYBC/NCBP express written permission.

Websites to which these pages are linked are for the convenience of users and are not managed by NYBC or NCBP. Please note that NYBC/NCBP does not review, control or take responsibility for the content of these Websites.

Disclosure Statement:

The NYBC's National Cord Blood Program Disclosure Statement is available upon request. Use Contact Us below to make your request.

Privacy Policy Statement:

The New York Blood Center's National Cord Blood Program welcomes your visit to our Website. If you use this Website to submit questions, you will be asked to provide person identification information such as your name and e-mail address (telephone number optional) to permit us to respond directly. Physicians and Transplant Center Coordinators will be asked to identify themselves when they register for log-in privileges. Formal Search Requests require personal identifying information about the patient. The New York Blood Center, its employees and agents will treat this information confidentially. We will not provide this information to any third party without the individual's authorization, except as may be required by law.

The information included on this Website and this privacy policy are subject to periodic review and change.

 

Dr. Pablo Rubinstein with Dr. Joanne Kurtzberg, Director of the Duke Pediatric Bone Marrow Transplant Program, at a reunion with children who received cord blood units from the NYBC's National Cord Blood Program.


 

Cord blood is an investigational product not licensed by the FDA.